Merck & Co. (MRK)

Total Non-Current Liabilities

$60.09B

Quarterly · Period ending: · USD

MRK logo

MRK Total Non-Current Liabilities

Latest reported$60.09B
MRK Quarterly Total Non-Current Liabilities ($1.06B → $60.09B)
High-resolution chart · PNG

MRK total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
60,087,000,000
55,809,000,000
55,877,000,000
49,011,000,000
42,426,000,000
41,548,000,000
42,314,000,000
43,386,000,000
42,922,000,000
40,326,000,000
43,346,000,000
42,333,000,000
42,333,000,000
37,760,000,000
38,863,000,000
39,559,000,000
40,609,000,000
43,399,000,000
43,565,000,000
33,903,000,000
35,394,000,000
37,447,000,000
38,857,000,000
40,125,000,000
40,693,000,000
35,130,000,000
36,176,000,000
35,722,000,000
36,143,000,000
36,141,000,000
33,549,000,000
33,888,000,000
34,146,000,000
35,180,000,000
34,689,000,000
33,710,000,000
34,334,000,000
36,650,000,000
37,865,000,000
38,823,000,000
38,111,000,000
37,286,000,000
37,709,000,000
37,970,000,000
38,436,000,000
39,986,000,000
30,979,000,000
30,521,000,000
31,416,000,000
33,426,000,000
35,451,000,000
38,198,000,000
38,369,000,000
31,792,000,000
32,321,000,000
32,506,000,000
30,940,000,000
31,613,000,000
31,940,000,000
32,345,000,000
32,510,000,000
33,364,000,000
33,335,000,000
34,924,000,000
33,084,200,000
34,795,300,000
35,188,000,000
15,364,400,000
15,163,200,000
11,125,700,000
11,709,900,000
12,106,700,000
15,072,800,000
15,285,200,000
15,501,100,000
12,035,400,000
12,021,600,000
14,216,700,000
11,881,300,000
10,849,100,000
11,269,900,000
10,837,100,000
11,218,500,000
11,452,200,000
12,019,400,000
12,129,400,000
11,133,600,000
10,835,800,000
11,290,700,000
11,341,600,000
11,526,300,000
11,491,200,000
12,609,900,000
12,469,100,000
12,057,200,000
11,820,700,000
11,773,600,000
11,550,300,000
11,589,400,000
10,615,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.